BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31554794)

  • 41. Naa20, the catalytic subunit of NatB complex, contributes to hepatocellular carcinoma by regulating the LKB1-AMPK-mTOR axis.
    Jung TY; Ryu JE; Jang MM; Lee SY; Jin GR; Kim CW; Lee CY; Kim H; Kim E; Park S; Lee S; Lee C; Kim W; Kim T; Lee SY; Ju BG; Kim HS
    Exp Mol Med; 2020 Nov; 52(11):1831-1844. PubMed ID: 33219302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LSR promotes epithelial ovarian cancer cell survival under energy stress through the LKB1-AMPK pathway.
    Takahashi Y; Serada S; Ohkawara T; Fujimoto M; Hiramatsu K; Ueda Y; Kimura T; Takemori H; Naka T
    Biochem Biophys Res Commun; 2021 Jan; 537():93-99. PubMed ID: 33388415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LKB1/Mo25/STRAD uniquely impacts sarcomeric contractile function and posttranslational modification.
    Behunin SM; Lopez-Pier MA; Birch CL; McKee LAK; Danilo C; Khalpey Z; Konhilas JP
    Biophys J; 2015 Mar; 108(6):1484-1494. PubMed ID: 25809261
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis.
    Chen L; Zhang W; Chen D; Yang Q; Sun S; Dai Z; Li Z; Liang X; Chen C; Jiao Y; Zhi L; Zhao L; Zhang J; Liu X; Zhao J; Li M; Wang Y; Qi Y
    Signal Transduct Target Ther; 2023 Apr; 8(1):159. PubMed ID: 37080995
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells.
    Lo AK; Lo KW; Ko CW; Young LS; Dawson CW
    J Pathol; 2013 Jul; 230(3):336-46. PubMed ID: 23592276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RAGE signaling mediates post-injury arterial neointima formation by suppression of liver kinase B1 and AMPK activity.
    Yu W; Liu-Bryan R; Stevens S; Damanahalli JK; Terkeltaub R
    Atherosclerosis; 2012 Jun; 222(2):417-25. PubMed ID: 22552116
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IGF-1 phosphorylates AMPK-alpha subunit in ATM-dependent and LKB1-independent manner.
    Suzuki A; Kusakai G; Kishimoto A; Shimojo Y; Ogura T; Lavin MF; Esumi H
    Biochem Biophys Res Commun; 2004 Nov; 324(3):986-92. PubMed ID: 15485651
    [TBL] [Abstract][Full Text] [Related]  

  • 48. AICAR induces phosphorylation of AMPK in an ATM-dependent, LKB1-independent manner.
    Sun Y; Connors KE; Yang DQ
    Mol Cell Biochem; 2007 Dec; 306(1-2):239-45. PubMed ID: 17786544
    [TBL] [Abstract][Full Text] [Related]  

  • 49. eNOS activation mediated by AMPK after stimulation of endothelial cells with histamine or thrombin is dependent on LKB1.
    Thors B; Halldórsson H; Thorgeirsson G
    Biochim Biophys Acta; 2011 Feb; 1813(2):322-31. PubMed ID: 21145922
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Arsenic inhibits neurite outgrowth by inhibiting the LKB1-AMPK signaling pathway.
    Wang X; Meng D; Chang Q; Pan J; Zhang Z; Chen G; Ke Z; Luo J; Shi X
    Environ Health Perspect; 2010 May; 118(5):627-34. PubMed ID: 20439172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Convergence of IPMK and LKB1-AMPK signaling pathways on metformin action.
    Bang S; Chen Y; Ahima RS; Kim SF
    Mol Endocrinol; 2014 Jul; 28(7):1186-93. PubMed ID: 24877601
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carnosic Acid against Lung Cancer: Induction of Autophagy and Activation of Sestrin-2/LKB1/AMPK Signalling.
    O'Neill EJ; Sze NSK; MacPherson REK; Tsiani E
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396629
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lovastatin induces multiple stress pathways including LKB1/AMPK activation that regulate its cytotoxic effects in squamous cell carcinoma cells.
    Ma L; Niknejad N; Gorn-Hondermann I; Dayekh K; Dimitroulakos J
    PLoS One; 2012; 7(9):e46055. PubMed ID: 23029387
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice.
    Li W; Hua B; Saud SM; Lin H; Hou W; Matter MS; Jia L; Colburn NH; Young MR
    Mol Carcinog; 2015 Oct; 54(10):1096-109. PubMed ID: 24838344
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of protein kinase C zeta by peroxynitrite regulates LKB1-dependent AMP-activated protein kinase in cultured endothelial cells.
    Xie Z; Dong Y; Zhang M; Cui MZ; Cohen RA; Riek U; Neumann D; Schlattner U; Zou MH
    J Biol Chem; 2006 Mar; 281(10):6366-75. PubMed ID: 16407220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CaMKKβ is involved in AMP-activated protein kinase activation by baicalin in LKB1 deficient cell lines.
    Ma Y; Yang F; Wang Y; Du Z; Liu D; Guo H; Shen J; Peng H
    PLoS One; 2012; 7(10):e47900. PubMed ID: 23110126
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CAB39L elicited an anti-Warburg effect via a LKB1-AMPK-PGC1α axis to inhibit gastric tumorigenesis.
    Li W; Wong CC; Zhang X; Kang W; Nakatsu G; Zhao Q; Chen H; Go MYY; Chiu PWY; Wang X; Ji J; Li X; Cai Z; Ng EKW; Yu J
    Oncogene; 2018 Dec; 37(50):6383-6398. PubMed ID: 30054562
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence against regulation of AMP-activated protein kinase and LKB1/STRAD/MO25 activity by creatine phosphate.
    Taylor EB; Ellingson WJ; Lamb JD; Chesser DG; Compton CL; Winder WW
    Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E661-9. PubMed ID: 16278246
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Unraveling ETC complex I function in ferroptosis reveals a potential ferroptosis-inducing therapeutic strategy for LKB1-deficient cancers.
    Mao C; Lei G; Horbath A; Wang M; Lu Z; Yan Y; Liu X; Kondiparthi L; Chen X; Cheng J; Li Q; Xu Z; Zhuang L; Fang B; Marszalek JR; Poyurovsky MV; Olszewski K; Gan B
    Mol Cell; 2024 May; 84(10):1964-1979.e6. PubMed ID: 38759628
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models.
    Waaler J; Mygland L; Tveita A; Strand MF; Solberg NT; Olsen PA; Aizenshtadt A; Fauskanger M; Lund K; Brinch SA; Lycke M; Dybing E; Nygaard V; Bøe SL; Heintz KM; Hovig E; Hammarström C; Corthay A; Krauss S
    Commun Biol; 2020 Apr; 3(1):196. PubMed ID: 32332858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.